At Creative Biolabs, we leverage our proprietary AI-enhanced technology to offer comprehensive, end-to-end antibody services. From de novo generation and screening to design, optimization, and engineering, we accelerate your drug development timelines and significantly reduce your time-to-market. We're here to streamline your journey and unlock the full potential of your therapeutic antibodies.
Explore what we can do
Ivelin Georgiev, PhD
Professor, Vanderbilt University Medical Center
Upcoming Webinar
We're accelerating traditional small molecule drug development by empowering target identification, high-throughput screening, and molecular design with AI. Our intelligent algorithms broaden your drug discovery path, helping you find novel compounds faster.
Based on our AI-aided drug discovery solutions, Creative Biolabs provides the best strategy and customized protocols for model training data service, and ultimately, to accelerate the novel candidate drug discovery.
Creative Biolabs offers customized solutions from de novo antibody creation and AI-augmented screening to AI-driven design and engineering final to phage display. Aided by this platform, we provide one-stop human antibody discovery services, including antibody-antigen binding prediction, antibody candidate generation, antibody sequence optimization, antibody production & characterization, etc.
We deliver quality, predictability, and results every time.
